At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
Furosemide +1 moredrug
Likely dose
Furosemide 20 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
MRI for the Non-invasive Determination of Renal Blood Flow and Renal Oxygenation
In Brief
A clinical study evaluating Furosemide and Placebo for Chronic Kidney Disease. Completed, enrolled 10 participants across 1 site.
Detailed Summary
Comparison of renal blood flow measurements by PAH clearance and MRI
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Kidney Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2010
First PostedMar 2011
Primary CompletionJun 2012
Study CompletionJun 2013
TodayJul 2026
First PostedMar 21, 2011
Enrollment StartOct 1, 2010
Primary CompletionJun 1, 2012
Study CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 15.3 years ago
Interventions
Furosemidedrug
Renal blood flow is measured after the administration of 20 mg of furosemide during MRI scan only.
Placeboother